A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers

Trial Profile

A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers

Discontinued
Phase of Trial: Phase III

Latest Information Update: 10 Oct 2017

At a glance

  • Drugs Placental-derived mesenchymal stem cell therapy Osiris Therapeutics (Primary)
  • Indications Diabetic foot ulcer
  • Focus Therapeutic Use
  • Sponsors Osiris Therapeutics
  • Most Recent Events

    • 05 Oct 2017 Status changed from active, no longer recruiting to discontinued.
    • 25 Jan 2017 Status changed from recruiting to active, no longer recruiting.
    • 06 Oct 2015 Status changed from planning to recruiting according to an Osiris Therapeutics media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top